1 |
Blumenthal M (2006) FDA approves special green tea extract as a new topical drug for genital warts. HerbalGram (Austin, Tex.) November 9
|
2 |
Liscinsky M (2012) FDA approves the first anti-diarrheal drug for HIV/AIDS patients. US Food and Drug Administration (Silver Spring, MD) December 31
|
3 |
American Botanical Council (2013) FDA approves CRO Elem eras first-several botanical drug. American Botanical Council (Austin,TX) January 2
|
4 |
Biotech Policy Research Center (2012) White paper on Research and Development in the Korean Pharmaceutical Industry. Biotech Policy Research Center 2012
|
5 |
Report on the Bioproducts Market and Trends in Biotechnology Development (2010) Ministry of Knowledge Economy/Korea Evaluation Institute of Industrial Technology/Korea Biotechnology Industry Organization
|
6 |
Biotech Policy Research Center (2012) Trends in Research and Development on Novel Botanical Medicine. Biotech Policy Research Center
|
7 |
US Food and Drug Administration (2013) Investigational New Drug application. US Food and Drug Administration September
|
8 |
Morphy R and Rankovic Z (2009) Designing multiple legends-medicinal chemistry strategies and challenges. Curr Pharm Des 15, 587-600
DOI
|
9 |
Zimmermann GR, Lehar J and Keith CT (2007) Multitarget therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 12, 34-42
DOI
|
10 |
Frantz S (2005) Drug discovery: playing dirty. Nature 437, 942-943
DOI
|
11 |
Parwardhan B and Mashelkar RA (2009) Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today 14, 804-811
DOI
|
12 |
Patwardhan B, Vaidya ADB, Chorghade M and Joshi SP (2008) Reverse pharmacology and systems approaches for drug discovery and development, Curr Bioact Compd 4, 1-11
DOI
|
13 |
Korea Biotechnology Industry Organization (2014) Seminar Presentation on the Strategy for Global Clinical Expansion of New Drug Development, Korea Biotechnology Industry Organization
|
14 |
Quality Standardization Based Botanical Drug Development Center (2013) Symposium Presentation on the Botanical Drug Material Development and Overseas Expansion Strategies. Quality Standardization Based Botanical Drug Development Center
|
15 |
Lee K (2014) Countermeasures by the Bio- and Pharmaceutical Industries against the Implementation of the Nagoya Protocol Regarding Access and Benefit-sharing. Gyeonggi Bio Insight
|
16 |
Oh S (2011) Status of Botanical Medicine Based on Plant-derivative Materials. Bioin Special
|
17 |
US Food and Drug Administration (2013) New Drug Application. US Food and Drug Administration website April 30
|
18 |
Son M (2014) Strategies and Case Studies of Research and Development of Novel Botanical Medicine by DongaST. Gyeonggi Bio Insight
|